Clinical trial
Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in…
NCT00086346 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00086346 |
|---|---|
| Title | Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients |
| Official title | A Randomized, Open-Label, Comparative Evaluation of Conversion From Calcineurin Inhibitor Treatment to Sirolimus Treatment Versus Continued Calcineurin Inhibitor Treatment in Liver Allograft Recipients Undergoing Maintenance Therapy |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | Sirolimus (Rapamune), Cyclosporine or Tacrolimus |
| Enrollment | 607 |
| Start date | Dec 1, 2002 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jul 2, 2004 |
| Last update posted | Apr 28, 2010 |
| Countries | Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: